Skip to content

The growing recognition that diseases impact broader aspects of patients’ lives and wellbeing has led to a deeper interest in patient-orientated indicators of health. Today, it is recognised that health can be measured partly by its impact on a patient’s quality of life.

For patients, quality of life is not just about being treated for their condition; it’s about feeling in control of their health and wellbeing and being able to take part in activities that are important to them. For pharma companies, understanding and measuring quality of life gains offered by their products is vital.

Download our white paper discussing the importance and challenges of measuring Quality of Life and how it enables Pharma to understand the real-world impact of their medications.